- Home
- XPER vs PEPG Comparison
XPER vs PEPG Comparison
Compare XPER & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPER
- PEPG
- Stock Information
- Founded
- XPER 1990
- PEPG 2018
- Country
- XPER United States
- PEPG United States
- Employees
- XPER N/A
- PEPG N/A
- Industry
- XPER Semiconductors
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- XPER Technology
- PEPG Health Care
- Exchange
- XPER Nasdaq
- PEPG Nasdaq
- Market Cap
- XPER 310.9M
- PEPG 317.6M
- IPO Year
- XPER 2003
- PEPG 2022
- Fundamental
- Price
- XPER $6.64
- PEPG $5.43
- Analyst Decision
- XPER Strong Buy
- PEPG Strong Buy
- Analyst Count
- XPER 2
- PEPG 6
- Target Price
- XPER $13.50
- PEPG $8.17
- AVG Volume (30 Days)
- XPER 468.8K
- PEPG 1.2M
- Earning Date
- XPER 11-05-2025
- PEPG 11-06-2025
- Dividend Yield
- XPER N/A
- PEPG N/A
- EPS Growth
- XPER N/A
- PEPG N/A
- EPS
- XPER N/A
- PEPG N/A
- Revenue
- XPER $475,219,000.00
- PEPG N/A
- Revenue This Year
- XPER N/A
- PEPG N/A
- Revenue Next Year
- XPER $6.47
- PEPG N/A
- P/E Ratio
- XPER N/A
- PEPG N/A
- Revenue Growth
- XPER N/A
- PEPG N/A
- 52 Week Low
- XPER $5.69
- PEPG $0.88
- 52 Week High
- XPER $11.08
- PEPG $7.97
- Technical
- Relative Strength Index (RSI)
- XPER 52.14
- PEPG 68.66
- Support Level
- XPER $6.44
- PEPG $4.36
- Resistance Level
- XPER $6.75
- PEPG $5.11
- Average True Range (ATR)
- XPER 0.23
- PEPG 0.37
- MACD
- XPER -0.02
- PEPG -0.10
- Stochastic Oscillator
- XPER 58.06
- PEPG 83.00
About XPER Xperi Inc.
Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.